All In MedTech

Device Trial Radar · NCT04394546

CHAMPION-AF Clinical Trial

WATCHMAN FLX Versus NOAC for Embolic ProtectION in in the Management of Patients With Non-Valvular Atrial Fibrillation

Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 3,000 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

3,000

Actual

Start

Oct 15, 2020

Primary completion

Dec 2027

Study completion Dec 2027

Sponsor

Lead sponsor
Boston Scientific CorporationPublic (BSX)
Sponsor type
Industry
First posted
May 19, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Prevention
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to determine if left atrial appendage closure (LAAC) with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.

Conditions

  • Atrial Fibrillation
  • Stroke
  • Bleeding

Interventions

  • WATCHMAN FLX LAAC DeviceDevice

    WATCHMAN FLX LAAC Device Implantation

  • Non-Vitamin K Oral AnticoagulantDrug

    Initiation or continuation of a NOAC drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. WATCHMAN FLX is non-inferior (NI) for the occurrence of stroke, cardiovascular death, and systemic embolismTime frame: 36-months
  2. WATCHMAN FLX is superior for non-procedural bleeding (ISTH major bleeding and clinically relevant non-major bleeding)Time frame: 36-months
  3. WATCHMAN FLX is non-inferior (NI) for the occurrence of ischemic stroke and systemic embolismTime frame: 60-months

Locations

141 sites in 16 countries. Site status is shown where the registry gives one.

  • Grandview Medical Center

    Birmingham, Alabama

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Arizona Arrhythmia Research Center

    Phoenix, Arizona

138 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.